- Home
- VIR vs MQY Comparison
VIR vs MQY Comparison
Compare VIR & MQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- MQY
- Stock Information
- Founded
- VIR 2016
- MQY 1994
- Country
- VIR United States
- MQY United States
- Employees
- VIR N/A
- MQY N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- MQY Investment Bankers/Brokers/Service
- Sector
- VIR Health Care
- MQY Finance
- Exchange
- VIR Nasdaq
- MQY Nasdaq
- Market Cap
- VIR 1.0B
- MQY 902.9M
- IPO Year
- VIR 2019
- MQY N/A
- Fundamental
- Price
- VIR $7.27
- MQY $11.70
- Analyst Decision
- VIR Buy
- MQY
- Analyst Count
- VIR 5
- MQY 0
- Target Price
- VIR $36.40
- MQY N/A
- AVG Volume (30 Days)
- VIR 1.2M
- MQY 184.8K
- Earning Date
- VIR 02-20-2025
- MQY 01-01-0001
- Dividend Yield
- VIR N/A
- MQY 4.73%
- EPS Growth
- VIR N/A
- MQY N/A
- EPS
- VIR N/A
- MQY N/A
- Revenue
- VIR $78,618,000.00
- MQY N/A
- Revenue This Year
- VIR N/A
- MQY N/A
- Revenue Next Year
- VIR N/A
- MQY N/A
- P/E Ratio
- VIR N/A
- MQY N/A
- Revenue Growth
- VIR N/A
- MQY N/A
- 52 Week Low
- VIR $6.56
- MQY $9.82
- 52 Week High
- VIR $13.09
- MQY $12.52
- Technical
- Relative Strength Index (RSI)
- VIR 42.92
- MQY 32.81
- Support Level
- VIR $7.22
- MQY $11.43
- Resistance Level
- VIR $7.64
- MQY $12.93
- Average True Range (ATR)
- VIR 0.35
- MQY 0.19
- MACD
- VIR -0.01
- MQY -0.07
- Stochastic Oscillator
- VIR 30.43
- MQY 19.71
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About MQY Blackrock MuniYield Quality Fund Inc.
Blackrock Muniyield Quality Fund Inc is a closed-end management investment company. The company's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.